Xiangyang Liu

机构：Shantou University, Institute of Plant Protection, Yue Bei People's Hospital, State Key Laboratory of New Ceramics and Fine Processing, Henan Agricultural University, Tsinghua University · ORCID：0000-0002-9064-3012

发表论文 27 篇 · 总被引 934 次 · h-index 12

代表论文

• Prognostic Role of microRNA-21 in Colorectal Cancer: a Meta-Analysis (2013 · PLoS ONE · 被引 66)
• Surgical treatments for degenerative lumbar scoliosis: a meta analysis (2015 · European Spine Journal · 被引 59)
• Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB–III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial (2021 · The Oncologist · 被引 43)
• Genome-Wide Association Study Identifies a Novel Susceptibility Locus at 12q23.1 for Lung Squamous Cell Carcinoma in Han Chinese (2013 · PLoS Genetics · 被引 43)
• Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway (2022 · Frontiers in Physiology · 被引 42)
• Protective effect of estrogen against intervertebral disc degeneration is attenuated by miR-221 through targeting estrogen receptor α (2018 · Acta Biochimica et Biophysica Sinica · 被引 33)